Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx

Abstract

During respiratory viral infections, the precise roles of monocytes and dendritic cells (DCs) in the nasopharynx in limiting infection and influencing disease severity are incompletely described. We studied circulating and nasopharyngeal monocytes and DCs in healthy controls (HC) and in patients with mild to moderate infections (primarily influenza A virus, IAV). As compared to HCs, patients with acute IAV infection displayed reduced DC but increased intermediate monocytes frequencies in blood, and an accumulation of most monocyte and DC subsets in the nasopharynx. IAV patients had more mature monocytes and DCs in the nasopharynx, and higher levels of TNFα, IL-6 and IFNα in plasma and the nasopharynx than HCs. In blood, monocytes were the most frequent cellular source of TNFα during IAV infection and remained responsive to additional stimulation with TLR7/8L. Immune responses in older patients skewed towards increased monocyte frequencies rather than DCs, suggesting a contributory role for monocytes in disease severity. In patients with other respiratory virus infections, we observed changes in monocyte and DC frequencies in the nasopharynx distinct from IAV patients, while differences in blood were more similar across infection groups. Using SomaScan, a high-throughput aptamer-based assay to study proteomic changes between patients and HCs, we found differential expression of innate immunity-related proteins in plasma and nasopharyngeal secretions of IAV and SARS-CoV-2 patients. Together, our findings demonstrate tissue-specific and pathogen-specific patterns of monocyte and DC function during human respiratory viral infections and highlight the importance of comparative investigations in blood and the nasopharynx.

Data availability

Source Data files have been provided for figures 1-7 and Appendix 2_Table 2 as separate excel files.

Article and author information

Author details

  1. Sindhu Vangeti

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3404-6878
  2. Sara Falck-Jones

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  3. Meng Yu

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  4. Björn Österberg

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  5. Sang Liu

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  6. Muhammad Asghar

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  7. Klara Sondén

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  8. Clare Paterson

    SomaLogic, Boulder, United States
    Competing interests
    Clare Paterson, is an employee and stockholder of SomaLogic Inc..
  9. Penn Whitley

    Boulder Bioconsulting Inc, Boulder, United States
    Competing interests
    No competing interests declared.
  10. Jan Albert

    Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9020-0521
  11. Niclas Johansson

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  12. Anna Färnert

    Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  13. Anna Smed-Sörensen

    Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
    For correspondence
    anna.smed.sorensen@ki.se
    Competing interests
    Anna Smed-Sörensen, is a consultant to Astra-Zeneca on studies not related to the present study..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6966-7039

Funding

Vetenskapsrådet

  • Anna Smed-Sörensen

Hjärt-Lungfonden

  • Anna Smed-Sörensen

Bill and Melinda Gates Foundation

  • Anna Smed-Sörensen

Barncancerfonden

  • Anna Smed-Sörensen

Karolinska Institutet

  • Anna Smed-Sörensen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Informed consent was obtained from all patients and volunteers following verbal and written information. The study was approved by the Swedish Ethical Review Authority (No. 2015/1949-31/4) and performed according to the Declaration of Helsinki.

Copyright

© 2023, Vangeti et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,019
    views
  • 244
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sindhu Vangeti
  2. Sara Falck-Jones
  3. Meng Yu
  4. Björn Österberg
  5. Sang Liu
  6. Muhammad Asghar
  7. Klara Sondén
  8. Clare Paterson
  9. Penn Whitley
  10. Jan Albert
  11. Niclas Johansson
  12. Anna Färnert
  13. Anna Smed-Sörensen
(2023)
Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx
eLife 12:e77345.
https://doi.org/10.7554/eLife.77345

Share this article

https://doi.org/10.7554/eLife.77345

Further reading

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    Lucia Csepregi, Kenneth Hoehn ... Sai T Reddy
    Research Article

    Diverse antibody repertoires spanning multiple lymphoid organs (i.e., bone marrow, spleen, lymph nodes) form the foundation of protective humoral immunity. Changes in their composition across lymphoid organs are a consequence of B-cell selection and migration events leading to a highly dynamic and unique physiological landscape of antibody repertoires upon antigenic challenge (e.g., vaccination). However, to what extent B cells encoding identical or similar antibody sequences (clones) are distributed across multiple lymphoid organs and how this is shaped by the strength of a humoral response remains largely unexplored. Here, we performed an in-depth systems analysis of antibody repertoires across multiple distinct lymphoid organs of immunized mice and discovered that organ-specific antibody repertoire features (i.e., germline V-gene usage and clonal expansion profiles) equilibrated upon a strong humoral response (multiple immunizations and high serum titers). This resulted in a surprisingly high degree of repertoire consolidation, characterized by highly connected and overlapping B-cell clones across multiple lymphoid organs. Finally, we revealed distinct physiological axes indicating clonal migrations and showed that antibody repertoire consolidation directly correlated with antigen specificity. Our study uncovered how a strong humoral response resulted in a more uniform but redundant physiological landscape of antibody repertoires, indicating that increases in antibody serum titers were a result of synergistic contributions from antigen-specific B-cell clones distributed across multiple lymphoid organs. Our findings provide valuable insights for the assessment and design of vaccine strategies.

    1. Immunology and Inflammation
    Yue Yang, Bin Huang ... Fangfang Zhang
    Research Article Updated

    Adipose tissue inflammation is now considered to be a key process underlying metabolic diseases in obese individuals. However, it remains unclear how adipose inflammation is initiated and maintained or the mechanism by which inflammation develops. We found that microRNA-802 (Mir802) expression in adipose tissue is progressively increased with the development of dietary obesity in obese mice and humans. The increasing trend of Mir802 preceded the accumulation of macrophages. Adipose tissue-specific knockout of Mir802 lowered macrophage infiltration and ameliorated systemic insulin resistance. Conversely, the specific overexpression of Mir802 in adipose tissue aggravated adipose inflammation in mice fed a high-fat diet. Mechanistically, Mir802 activates noncanonical and canonical NF-κB pathways by targeting its negative regulator, TRAF3. Next, NF-κB orchestrated the expression of chemokines and SREBP1, leading to strong recruitment and M1-like polarization of macrophages. Our findings indicate that Mir802 endows adipose tissue with the ability to recruit and polarize macrophages, which underscores Mir802 as an innovative and attractive candidate for miRNA-based immune therapy for adipose inflammation.